慢性牙周炎患者牙龈组织中IL-6、IL-34和M-CSFR的表达及临床意义

目的: 比较慢性牙周炎患者牙龈组织和健康牙龈组织中IL-6、IL-34及M-CSFR的表达水平,探讨IL-34 在慢性牙周炎发病中的作用。方法: 收集8例诊断为轻度慢性牙周炎患牙的牙龈组织和8例诊断为重度慢性牙周炎患牙的牙龈组织作为病例组,8例冠延长手术切除的牙龈组织作为对照组,应用实时荧光定量PCR检测IL-6、IL-34及M-CSFR mRNA的表达;应用蛋白免疫印迹检测IL-6、IL-34及M-CSFR蛋白的表达。使用GraphPad Prism 6.0对结果进行统计学分析。结果: IL-6、IL-34、M-CSFR mRNA及蛋白在慢性牙周炎牙龈组织中的表达水平均显著高于正常牙龈组织中的表达（P<0.05）。结论: IL-6、IL-34及M-CSFR的表达可能与慢性牙周炎密切相关。     

IL-10mRNA及其蛋白在慢性牙周炎牙龈组织中的表达

目的检测IL-10 mRNA及其蛋白在慢性牙周炎牙龈组织中的表达及其组织细胞来源.方法随机选择12例慢性牙周炎翻瓣术患者作为牙周炎组,10例龈切术患者作为牙龈炎组,6例阻生牙拔除术患者作为健康对照组.分别采用原位杂交和免疫组化检测技术,检测各组牙龈标本中IL-10的表达.每组IL-10 mRNA及蛋白两种水平间的比较采用秩和检验;各组间数据的两两比较采用单因素方差分析.结果IL-10 mRNA及其蛋白在牙周局部牙龈组织均有表达,表达细胞类型有淋巴细胞、浆细胞、巨噬细胞及成纤维细胞等.IL-10在mRNA水平及蛋白水平表达无显著差异(P＞0.05)(牙龈炎组P＜0.05).牙周炎组IL-10表达强度显著高于健康对照组和牙龈炎组(P＜0.01),牙周炎组IL-10 mRNA表达强度显著高于健康对照组(P＜0.01),但与牙龈炎组比较差异无显著性(P＞0.05).结论IL-10在牙周组织中存在局部分泌机制.     

β-防御素基因在牙龈组织中的表达

目的:检测人β-防御素(HBD-1,-2,-3)基因在牙周炎病变和健康牙龈组织中的表达。方法:应用反转录多聚合酶链反应(RT-PCR)技术检测健康牙龈(HC组,11例)、慢性牙周炎(CP组,12例)和侵袭性牙周炎(AgP组,9例)牙龈组织中HBD-1、HBD-2和HBD-3mRNA表达水平。结果:HBD-1,-2,-3在所有牙龈组织样本中均有mRNA表达;HBD-3mRNA在HC组、CP组、AgP组的表达水平分别为0.53±0.12,0.30±0.17和0.40±0.17,3组间差异有统计学意义(P<0.01),健康牙龈中HBD-3mRNA表达相对强度明显高于慢性牙周炎组;HBD-2和HBD-3基因的mRNA表达水平呈正相关(P<0.01,r=0.48)。结论:牙龈上皮表达的β-防御素(HBD-1,-2,-3),尤其是HBD-3在健康牙龈组织较高水平的mRNA表达,提示其在牙周宿主免疫防御反应中可能发挥重要作用。     

牙周炎和健康人牙周组织中细胞焦亡水平的比较研究

目的:研究慢性牙周炎和健康人的牙周组织中细胞焦亡水平是否存在差异。方法:分别纳入全身健康、无牙周病史、牙列完整的患者9例作为健康对照组，慢性牙周炎III～IV期患者9例作为牙周炎组。收集患者的牙周组织，免疫组化染色对牙龈组织中消皮素D(GSDMD)、半胱天冬酶-1(caspase-1)、NLRP3炎症小体、白细胞介素-1β(IL-1β)、白细胞介素-18(IL-18)的表达水平及分布进行定性分析；实时定量PCR检测牙龈组织和牙周膜组织中GSDMD、caspase-1、NLRP3、IL-1β及IL-18 mRNA的表达差异。结果:免疫组化染色显示牙周炎组的牙龈组织中GSDMD、caspase-1、NLRP3、IL-1β、IL-18的阳染色面积均大于健康组(P<0.05)。实时定量PCR检测显示，牙周炎组牙龈组织和牙周膜组织中GSDMD、caspase-1、NLRP3、IL-1β、IL-18 mRNA的表达量明显高于健康组(P<0.05)。结论:慢性牙周炎牙周组织的细胞焦亡水平高于健康人，提示细胞焦亡可能参与了牙周炎的发生发展。     

慢性牙周炎患者IL-17mRNA的表达及意义

目的：观察TL-17mRNA基因在慢性牙刷炎和健康牙龈组织中的表达水平变化,探讨TL-17在慢性牙周炎发生发展巾的作用。方法：选择慢性牙周炎患者23例,正常对照组15例,记录才周临床指标,采用Real—time PCR方法定量检测TL-17mRNA在牙龈组织中的表达。结果：慢性牙周炎组TL-17mRNA相对表达晕（0．00147＋0．00055）显著高于正常牙龈组（O．00047±0．00019）（P〈0．01）,并且慢性牙周炎组TL-17mRNA表达水平与牙龈指数（r=0．58,P〈0．01）、牙周袋探诊深度（r=0．57,P〈0．01）、附着丧失水平（r=0．49,P〈0．05）呈正相关。结论：Th17相关细胞凶子IL—17呵能住慢性牙周炎发病机制中发挥致炎作用。     

β-防御素-2多肽在不同类型牙周炎及健康牙龈组织中的表达

目的:检测人β-防御素-2(humanbetadefensin-2,HBD-2)在牙周病病变牙龈和健康牙龈中的表达。方法:应用SP法检测健康牙龈(HC组,11例)、慢性牙周炎(CP组,18例)和侵袭性牙周炎(AgP组,9例)牙龈中HBD-2蛋白的表达水平,所得数据用SPSS11.5统计分析软件进行单因素方差分析。结果:HBD-2蛋白在所有牙龈标本中均有表达;HBD-2蛋白表达可见于牙龈复层鳞状上皮全层,主要位于棘层以上细胞胞质内。3组的表达水平分别为:健康牙龈组(31.55±12.66)%、慢性牙周炎组(17.31±7.64)%、侵袭性牙周炎组(25.06±8.04)%,健康组表达水平显著高于慢性牙周炎组(P<0.05),其他组间差异无统计学意义。结论:HBD-2多肽在健康牙龈和牙周病牙龈上皮中广泛表达,提示其在维系牙周健康及宿主免疫防御反应中可能发挥重要作用。     

慢性牙周炎牙龈组织细胞凋亡及凋亡相关蛋白Caspase-3的表达

目的:研究慢性牙周炎牙龈组织中细胞凋亡的发生情况和Caspase-3蛋白的表达,探讨其在慢性牙周炎病变发生中的意义。方法:应用脱氧核糖核苷酸末端转移酶介导的原位缺口末端标记法(TUNEL法)、免疫组织化学方法检测21例慢性牙周炎牙龈组织和21例健康牙龈组织中的细胞凋亡指数(apoptosis index,AI)及Caspase-3蛋白的表达。结果:慢性牙周炎组牙龈组织中细胞凋亡指数明显高于正常对照组(P<0.05)。与正常组相比,慢性牙周炎组牙龈组织中细胞caspase-3表达明显增强,两组间有显著性差异(P<0.05)。结论:慢性牙周炎病人牙龈组织细胞发生凋亡,且通过激活细胞凋亡信号传导途径中的Caspase-3而导致慢性牙周炎发生。     

IL-1β与IL-10mRNA在牙龈组织中的表达

目的:检测IL-1β与IL-10mRNA在正常牙龈及牙周炎患者牙龈组织中的表达,探讨二者与炎症的关系及内源性抗炎因子IL-10对致炎因子IL-1β是否有拮抗作用。方法:采集14例成人牙周炎患者炎症区牙龈组织,6例正常牙龈组织,利用逆转录-聚合酶链反应检测其中IL-1β与IL-10mRNA的表达及其强弱程度。结果:成人牙周炎组牙龈组织IL-1βmRNA的阳性表达率为92.86%,IL-10mRNA阳性表达率为71.43%,二者与正常对照组相比均有显著性差异;两者之间无明显相关性;两者与临床指标间亦无明显相关性。结论:致炎性和抗炎性细胞因子均可在牙龈组织中表达;机体自身IL-10水平不足以完全拮抗IL-1β活性;IL-10对致炎性细胞因子IL-1β的调控作用有待进一步研究。     

慢性牙周炎患者牙龈组织内诱导型一氧化氮合酶表达的研究

目的:研究牙周健康者和慢性牙周炎患者牙龈组织中诱导型一氧化氮合酶的表达强度,探讨一氧化氮在牙周病发病过程中的作用.方法:选择牙周健康组、慢性牙周炎活动期组,慢性牙周炎静止期组各20例,采取免疫组织化学的方法染色,光镜下观察牙龈组织内诱导型一氧化氮合酶的表达强度.结果:慢性牙周炎时牙龈组织中诱导型一氧化氮合酶主要在鳞状上皮和间质组织的细胞胞浆中阳性表达,正常组表达强度弱于慢性牙周炎静止期组和活动期组,慢性牙周炎静止期组表达强度弱于慢性牙周炎活动期组.结论:一氧化氮参与了慢性牙周炎的发生和发展过程,牙龈组织中诱导型一氧化氮合酶的表达强度与慢性牙周炎的炎症程度密切相关.     

慢性牙周炎与健康牙龈组织中MMP-1的表达和意义

目的:通过检测基质金属蛋白酶-1(MMP-1)在慢性牙周炎牙龈组织中的表达和分布特征,探讨MMP-1在慢性牙周炎发病中的作用和临床意义。方法:收集8例因非牙周疾病而需拔牙患者健康牙龈及24例慢性牙周炎患者牙龈组织,按健康对照、牙周袋深度≤4mm、4~6mm、>6mm分A、B、C、D四组,利用免疫组化方法检测其中MMP-1的表达。结果:正常牙龈组织上皮及固有层MMP-1弱表达,慢性牙周炎患者牙龈组织MMP-1表达明显增高,两者间有显著性差异(P<0.05)。并且MMP-1表达与牙周袋深度间显著正相关(r=0.623,P<0.01)。结论:MMP-1参与慢性牙周炎病变牙周组织的破坏过程,并且其表达随牙周袋深度加深有增加趋势。     

Ⅱ型糖尿病伴牙周炎病人牙龈组织中VEGF表达及MVD计数的研究

目的:探讨Ⅱ型糖尿病伴牙周炎病人牙龈组织中血管内皮生长因子(VEGF)的表达水平及其作用。方法:选取Ⅱ型糖尿病伴重度牙周炎(DP)病人、单纯重度慢性牙周炎(CP)病人、健康对照者(N)各15例,分别切取牙龈组织,用免疫组化染色方法检测牙龈组织中VEGF表达和MVD计数。结果:DP组牙龈组织中VEGF表达和MVD计数均显著高于CP组和N组(P<0.05);CP组高于N组(P<0.05)。结论:Ⅱ型糖尿病伴重度慢性牙周炎病人牙龈组织中VEGF表达水平和MVD计数明显升高。     

Estimation of Pentraxin‐3 Levels in the Gingival Tissues of Chronic and Aggressive Periodontitis Participants: An In Vivo Study

Background: Pentraxins are acute‐phase proteins that belong to a family of evolutionarily conserved proteins, and they are considered markers of inflammation. Pentraxin‐3 (PTX3) is a prototype of the long pentraxin group. It is suggested to play an important role in innate resistance against pathogens, regulation of inflammation, and clearance of apoptotic cells. The aim of this study is to estimate the level of PTX3 in gingival tissues of individuals with chronic (CP) and aggressive (AgP) periodontitis and control participants and further correlate the level of PTX3 with clinical parameters. Methods: The study population consisted of 50 participants ranging in age from 20 to 55 years and attending the outpatient section of Department of Periodontics, Saveetha Dental College and Hospital, Chennai, India. The study groups included the following: 1) group A, patients with generalized CP (n = 20); 2) group B (n = 20), patients with generalized AgP (GAgP); and 3) group C (n = 10), healthy controls. Tissue samples from participants were assayed for PTX3 levels using enzyme‐linked immunosorbent assay. Results: Gingival tissues from patients with GAgP (8.349 ± 5.076 ng/mL) had a higher mean concentration of PTX3 than tissues from patients with generalized CP (5.068 ± 3.274 ng/mL) and controls (0.251 ± 0.277). The PTX3 levels in the gingival tissues correlated positively with clinical parameters in all the groups. Among the parameters, probing depth was the most significant predictor variable associated with PTX3 in cases with periodontitis. Conclusions: PTX3 concentration in gingival tissues of patients with GAgP was higher than in tissues from patients with CP, and the levels correlated positively with clinical parameters. Hence, tissue PTX3 level can be considered a marker of inflammation in periodontal disease.     

Influence of Periodontal Clinical Status on Salivary Levels of Glutathione Reductase

Background: Inadequate antioxidant balance may play a role in the excessive tissue breakdown in periodontitis. Because aggressive periodontitis (AgP) not only differs from chronic periodontitis (CP) in terms of clinical manifestations, this study investigates whether the salivary levels of glutathione reductase (GR) may be linked with periodontal status. Methods: Saliva samples from patients with CP (n = 121), patients with AgP (n = 18), and healthy controls (n = 69) were collected. Periodontal status was assessed by criteria based on probing depth, clinical attachment level, and extent and severity of periodontal breakdown. GR salivary levels were analyzed by spectrophotometry. The association among GR concentration and CP or AgP was analyzed individually and adjusted for confounding using multivariate binary logistic regression models. Results: GR levels not only differed significantly between the two periodontitis groups, being significantly greater in patients with AgP, but also were significantly greater than those observed in healthy controls. Synchronously, positive significant correlations between salivary GR concentration and clinical parameters were observed. After binary logistic regression analysis, both GR salivary levels ≥15.38 and ≥24.20 mU/mL were associated independently with CP and AgP, respectively. A significant interaction effect was also detected between increased GR salivary concentration and aging in the CP group. Conclusions: Increased GR salivary concentration may be a strong/independent prognostic indicator of the amount and extent of oxidative stress‐induced periodontal damage in both CP and AgP. Likewise, saliva samples might reflect an interactive effect of GR levels associated with the aging‐related cumulative characteristics of periodontal damage in CP.     

Gingival crevicular fluid matrix metalloproteinase-13 levels and molecular forms in various types of periodontal diseases

BACKGROUND: The purpose of this study was to evaluate the levels, molecular forms and activation degree of matrix metalloproteinase-13 (MMP-13) in the gingival crevicular fluid (GCF) of patients with periodontal diseases and to correlate these findings with periodontal clinical parameters. METHODS: Sixty one subjects participated in this study as healthy (n = 18), gingivitis (n = 17), aggressive periodontitis (AgP; n = 15) and chronic periodontitis (CP; n = 11) groups. Clinical measurements and GCF samples were obtained from each subject. The molecular forms of MMP-13 in GCF samples were analyzed by Western immunoblotting method. Differences among the groups were assessed using non-parametric statistical analysis. RESULTS: In the CP group, levels of 29-30 kDa fragment of MMP-13, total MMP-13, and activated form of MMP-13 were significantly higher than in the healthy, gingivitis and AgP groups. GCF levels of all molecular forms of MMP-13 in AgP group were similar to those of healthy and gingivitis groups. Total and activated MMP-13 levels were positively correlated with all clinical parameters. 29-30 kDa fragment levels of MMP-13 were also positively correlated with papillary bleeding index and plaque index. CONCLUSION: These results indicate that elevated GCF MMP-13 levels may play an important role in the pathogenesis of CP. These data demonstrate, for the first time, pathologically activated and elevated MMP-13 in GCF.     

Expression of Leptin and Visfatin in Gingival Tissues of Chronic Periodontitis With and Without Type 2 Diabetes Mellitus: A Study Using Enzyme‐Linked Immunosorbent Assay and Real‐Time Polymerase Chain Reaction

Background: The aim of this study is to investigate the protein and gene expression of leptin and visfatin in gingival tissue from patients with chronic periodontitis (CP), patients with CP and type 2 diabetes mellitus (T2DM), and healthy individuals. Methods: The study includes 50 individuals: 10 healthy individuals, 20 patients with CP, and 20 patients with CP and T2DM. Plaque index, gingival index, probing depth, and clinical attachment loss were measured, and gingival biopsies were obtained. Leptin and visfatin protein expression in gingival tissues was determined using enzyme‐linked immunosorbent assay, and messenger RNA (mRNA) expression was measured via real‐time polymerase chain reaction. Results: The highest leptin mRNA and protein expression was observed in the control group and was significantly (P ≤0.05) different from the CP and CP+T2DM groups. Gingival tissues from patients with CP and T2DM had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with CP. Conclusion: Expression of leptin and visfatin in the gingival tissues suggests a possible role for these adipokines in the pathogenesis of CP and T2DM.